Childhood cancers trials in Australia

In Australia 98 Also abroad 2481

98 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
A Study to Give Treatment Inside the Eye to Treat Retinoblastoma
Where
Parkville, Perth
Age
Up to 18 years
People
26 worldwide
Run by
Children's Oncology Group
See details and how to joinNCT05504291
Phase 2Taking people
A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma
Where
Hunter Regional Mail Centre, North Adelaide, Parkville, Perth, Randwick, South Brisbane, Westmead
Age
3 years to 29 years
People
240 worldwide
Run by
Children's Oncology Group
See details and how to joinNCT06368817
Phase 3Taking people
A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)
Where
South Brisbane
Age
Up to 30 years
People
1,656 worldwide
Run by
Children's Oncology Group
See details and how to joinNCT06401330
Phase 1/2Taking people
A Study of CTD402 in T-ALL/LBL Patients
Where
Sydney
Age
1 year and over
People
118 worldwide
Run by
Imviva Bio
See details and how to joinNCT07070219
Phase 1Enrolling by invitation
Adoptive Cell Therapy Long-term Follow-up (LTFU) Study
Where
Melbourne
People
250 worldwide
Run by
USWM CT, LLC
See details and how to joinNCT03391778
Phase 2Taking people
A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
Where
Camperdown, Melbourne
Age
1 year to 39 years
People
105 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT05999994
Phase 2Taking people
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Where
Bedford Park, Melbourne, New Lambton Heights, Orange, Randwick
Age
8 years and over
People
254 worldwide
Run by
Fore Biotherapeutics
See details and how to joinNCT05503797 · EU 2024-513578-23-00
Phase 1/2Taking people
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors
Where
Melbourne, Miranda, Nedlands, Wollongong, Wollstonecraft
Age
12 years and over
People
361 worldwide
Run by
ModernaTX, Inc.
See details and how to joinNCT05533697 · EU 2023-504506-11-00
Phase 3Taking people
Brentuximab Vedotin in Early Stage Hodgkin Lymphoma
Where
Adelaide, Box Hill, Brisbane, Darwin, Liverpool, Melbourne, Saint Leonards, Sydney, Townsville
Age
16 years to 69 years
People
1,042 worldwide
Run by
University College, London
See details and how to joinNCT04685616 · EU 2022-500031-37-00
No phaseTaking people
Physical Activity and Exercise During Early Treatment Phases for Childhood Acute Lymphoblastic Leukaemia to Protect Against Muscle Loss and Improve Frailty Outcomes
Where
Melbourne
Age
5 years to 17 years
People
60
Run by
Murdoch Childrens Research Institute
See details and how to joinNCT07325305
Early phase 1Taking people
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
Where
Perth, Randwick, South Brisbane
Age
1 year to 21 years
People
15 worldwide
Run by
Nationwide Children's Hospital
See details and how to joinNCT06333899
Phase 2Taking people
Combination Therapy for the Treatment of Diffuse Midline Gliomas
Where
Adelaide, Clayton, Melbourne, Nedlands, New Lambton Heights, South Brisbane, Sydney, Westmead
Age
2 years to 39 years
People
360 worldwide
Run by
University of California, San Francisco
See details and how to joinNCT05009992 · EU 2023-507598-16-00
No phaseTaking people
Metastatic Leiomyosarcoma Biomarker Protocol
Where
Camperdown, Melbourne
People
200 worldwide
Run by
University of Michigan Rogel Cancer Center
See details and how to joinNCT05653388
Phase 2Taking people
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
Where
Melbourne, Perth, Randwick, South Brisbane
Age
12 months to 39 years
People
120 worldwide
Run by
Nationwide Children's Hospital
See details and how to joinNCT05843253
Phase 1/2Taking people
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Where
Adelaide, Camperdown, East Melbourne, Melbourne
Age
12 years and over
People
500 worldwide
Run by
Turning Point Therapeutics, Inc.
See details and how to joinNCT03093116 · EU 2024-512606-25-00
No phaseTaking people
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
Where
Perth
People
420 worldwide
Run by
Children's Oncology Group
See details and how to joinNCT01790152
Phase 2Taking people
ACTEMRA® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma
Where
Perth, Randwick, South Brisbane
Age
1 year to 39 years
People
30 worldwide
Run by
Nationwide Children's Hospital
See details and how to joinNCT05233397
Phase 2Taking people
Tovorafenib for Treatment of Craniopharyngioma in Children and Young Adults
Where
Clayton, Hobart, Nedlands, New Lambton Heights, Parkville
Age
1 year to 39 years
People
57 worldwide
Run by
Sabine Mueller, MD, PhD
See details and how to joinNCT05465174 · EU 2024-511510-20-00
Phase 3Taking people
ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study)
Where
Heidelberg, Herston, Hobart, Nedlands, Randwick, Sydney
People
510 worldwide
Run by
Jazz Pharmaceuticals
See details and how to joinNCT05580562 · EU 2022-502051-56-00
Phase 2Taking people
Pharmacogenomics for Better Treatment of Fungal Infections Clinical Trial
Where
Adelaide, Brisbane, Melbourne, South Brisbane, Sydney
Age
2 years and over
People
104 worldwide
Run by
The University of Queensland
See details and how to joinNCT06510699
Phase 2Taking people
MEKTOVI® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma
Where
Perth, Randwick, South Brisbane
Age
1 year to 39 years
People
38 worldwide
Run by
Nationwide Children's Hospital
See details and how to joinNCT05286788
Phase 2/3Taking people
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
Where
Melbourne, Wollstonecraft
Age
18 years and over
People
280 worldwide
Run by
Replimune, Inc.
See details and how to joinNCT06581406 · EU 2023-508784-68-00
Early phase 1Taking people
A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion
Where
Perth, Randwick, South Brisbane
Age
Up to 21 years
People
15 worldwide
Run by
Nationwide Children's Hospital
See details and how to joinNCT04655404 · EU 2023-508953-16-00
Phase 2Taking people
International Study for Treatment of High Risk Childhood Relapsed ALL 2010
Where
Clayton
Age
Up to 17 years
People
250 worldwide
Run by
Charite University, Berlin, Germany
See details and how to joinNCT03590171 · EU 2024-513070-21-00
No phaseTaking people
Primary Tumor Research and Outcomes Network
Where
Brisbane
People
1,350 worldwide
Run by
AO Innovation Translation Center
See details and how to joinNCT02790983